This is consistent with the results of previous studies in which patient factors (age, DM, and platelet count)31–33, liver background factors (liver cirrhosis)34, and tumor factors (TNM stage, and AFP)35 contributed to the outcomes of HCC patients. The gene discussed is AFP; the disease is neoplasm.